Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $12.25 Average Price Target from Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have received an average rating of “Buy” from the six analysts that are currently covering the company, Marketbeat reports. Four research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month price target among brokers that have covered the stock in the last year is $12.25.

Several equities analysts recently weighed in on BIOX shares. Roth Mkm cut their price objective on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Oppenheimer cut their price target on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, October 21st. Lake Street Capital decreased their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, September 11th. Canaccord Genuity Group lowered their target price on shares of Bioceres Crop Solutions from $12.50 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, October 17th. Finally, Canaccord Genuity Group raised Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th.

Bioceres Crop Solutions Trading Down 3.4 %

Bioceres Crop Solutions stock opened at $6.49 on Thursday. Bioceres Crop Solutions has a 12 month low of $6.48 and a 12 month high of $14.05. The company has a quick ratio of 0.91, a current ratio of 1.28 and a debt-to-equity ratio of 0.35. The stock has a market cap of $407.90 million, a P/E ratio of 162.29 and a beta of 0.49. The company’s fifty day simple moving average is $8.30 and its 200-day simple moving average is $10.13.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its earnings results on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.23). The firm had revenue of $124.30 million during the quarter, compared to analyst estimates of $126.75 million. Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. During the same period in the previous year, the company earned ($0.06) earnings per share. As a group, sell-side analysts forecast that Bioceres Crop Solutions will post 0.31 EPS for the current fiscal year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently made changes to their positions in BIOX. Oak Family Advisors LLC boosted its stake in Bioceres Crop Solutions by 1.9% during the 2nd quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock valued at $728,000 after purchasing an additional 1,208 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after acquiring an additional 5,341 shares during the period. Oppenheimer & Co. Inc. acquired a new stake in shares of Bioceres Crop Solutions in the first quarter worth $139,000. Lazard Asset Management LLC bought a new position in Bioceres Crop Solutions during the first quarter worth $212,000. Finally, Ping Capital Management Inc. acquired a new position in Bioceres Crop Solutions during the 2nd quarter valued at $448,000. 17.68% of the stock is owned by institutional investors and hedge funds.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.